Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
出版年份 2022 全文链接
标题
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-09-09
DOI
10.3389/fimmu.2022.949746
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease
- (2022) Qi Xie et al. Aging-US
- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
- (2022) Tzu-Tang Wei et al. CELL
- Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
- (2022) Noel Salvoza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genistein, a tool for geroscience
- (2022) Cristina Mas- Bargues et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Effect of Turmeric Supplementation on Blood Pressure and Serum Levels of Sirtuin 1 and Adiponectin in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
- (2022) Ali Kalhori et al. Preventive Nutrition and Food Science
- Nonalcoholic fatty liver disease: another leap forward
- (2021) Manal F. Abdelmalek Nature Reviews Gastroenterology & Hepatology
- Functional relationship of vegetable colors and bioactive compounds: implications in human health
- (2021) Shweta Sharma et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application
- (2021) Hang-Yu Li et al. Oxidative Medicine and Cellular Longevity
- Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
- (2021) Ludovico Abenavoli et al. Nutrients
- Polyphenol‐Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery
- (2021) Yuxin Guo et al. ADVANCED MATERIALS
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review
- (2021) Arshad Mehmood et al. FOOD RESEARCH INTERNATIONAL
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
- (2021) Mengyao Zhao et al. PHARMACOLOGICAL RESEARCH
- Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
- (2021) Oriol Juanola et al. International Journal of Environmental Research and Public Health
- The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
- (2021) Rosa Martín-Mateos et al. Frontiers in Immunology
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
- (2021) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
- (2021) Frank Tacke et al. Annals of Translational Medicine
- Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
- (2021) Zahra Namkhah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms
- (2021) Xiaohui Zhang et al. LIFE SCIENCES
- Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
- (2021) Emir Muzurović et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits
- (2021) Javad Sharifi-Rad et al. Oxidative Medicine and Cellular Longevity
- Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)—A Review
- (2021) Gracjan Różański et al. Nutrients
- Genistein: Dual Role in Women’s Health
- (2021) Linda Yu et al. Nutrients
- Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
- (2021) Guoyi Tang et al. Antioxidants
- Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
- (2021) Fatemeh Naeini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- (Poly)phenol toxicity in vivo following oral administration: A targeted narrative review of (poly)phenols from green tea, grape, and anthocyanin‐rich extracts
- (2021) Dennis P. Cladis et al. PHYTOTHERAPY RESEARCH
- The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial
- (2021) Maryam jarhahzadeh et al. Diabetology & Metabolic Syndrome
- Curcumin in Metabolic Health and Disease
- (2021) Marzena Jabczyk et al. Nutrients
- Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
- (2021) Rocío Gallego-Durán et al. Frontiers in Immunology
- Hepatic Macrophage as a Key Player in Fatty Liver Disease
- (2021) Liyun Xu et al. Frontiers in Immunology
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
- (2021) Paulina Głuszyńska et al. Journal of Clinical Medicine
- Drug Delivery Strategies for Curcumin and Other Natural Nrf2 Modulators of Oxidative Stress-Related Diseases
- (2021) Nina Katarina Grilc et al. Pharmaceutics
- Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity
- (2021) Xin Xin et al. Frontiers in Nutrition
- Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2020) Maryam Saberi-Karimian et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Epidemiology of Non-alcoholic Fatty Liver Disease in North America
- (2020) Tamoore Arshad et al. CURRENT PHARMACEUTICAL DESIGN
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?
- (2020) Judith Aron-Wisnewsky et al. GASTROENTEROLOGY
- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- Beneficial Properties of Green Tea Catechins
- (2020) Claudia Musial et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials
- (2020) Marzieh Mahmoodi et al. PHYTOTHERAPY RESEARCH
- Dietary polyphenol impact on gut health and microbiota
- (2020) Murphy L. Y Wan et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Hepatoprotective effects of resveratrol in non-alcoholic fatty live disease
- (2020) Silvia Tejada et al. CURRENT PHARMACEUTICAL DESIGN
- Non-Alcoholic Fatty Liver Disease and Vascular Disease
- (2020) Pinelopi Manousou et al. Current Vascular Pharmacology
- The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
- (2020) Yun Ji et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice
- (2020) Erhan Sahin et al. JOURNAL OF FOOD BIOCHEMISTRY
- A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial
- (2020) Mitra Hariri et al. COMPLEMENTARY THERAPIES IN MEDICINE
- The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
- (2020) Zahra Yari et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
- (2020) Gianluca Svegliati-Baroni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-inflammatory Activities of Green Tea Catechins along the Gut-liver Axis in Nonalcoholic Fatty Liver Disease: Lessons Learned from Preclinical and Human Studies
- (2020) Joanna K. Hodges et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice
- (2020) Si-wei Wang et al. Nutrition & Diabetes
- Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
- (2020) Haiou Li et al. Frontiers in Immunology
- Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
- (2020) Maryam Mahjoubin-Tehran et al. Molecular Metabolism
- Redefining fatty liver disease: an international patient perspective
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals
- (2020) Shamee Bhattacharjee et al. Antioxidants
- Metabolic drivers of non-alcoholic fatty liver disease
- (2020) Kendra K. Bence et al. Molecular Metabolism
- Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
- (2020) Kalliopi Pafili et al. Molecular Metabolism
- A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
- (2019) Saeed Chashmniam et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease
- (2019) Saeede Saadati et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function
- (2019) Hossein Rafiei et al. Nutrients
- Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
- (2019) Seyed Ali Jazayeri-Tehrani et al. Nutrition & Metabolism
- No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease
- (2019) L. Farzin et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
- (2019) Arrigo F. G. Cicero et al. EUROPEAN JOURNAL OF NUTRITION
- Treatment options for nonalcoholic fatty liver disease
- (2019) Amir Anushiravani et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD)
- (2019) Aida Ghaffari et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway
- (2019) Yujie Huang et al. Applied Physiology Nutrition and Metabolism
- Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
- (2019) Saeede Saadati et al. BMC GASTROENTEROLOGY
- Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial
- (2019) Yunes Panahi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2019) Seyed Reza Mirhafez et al. Journal of Gastrointestinal and Liver Diseases
- The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial
- (2019) Zohreh Sadat Sangsefidi et al. Nutrition Journal
- Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial
- (2019) Makan Cheraghpour et al. PHYTOTHERAPY RESEARCH
- Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
- (2019) Victor J. Navarro et al. PLoS One
- Recent Research on the Health Benefits of Blueberries and Their Anthocyanins
- (2019) Wilhelmina Kalt et al. Advances in Nutrition
- Non‐alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management
- (2019) Tony (Dazhong) Huang et al. INTERNAL MEDICINE JOURNAL
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
- (2019) Alessandro Federico et al. Oxidative Medicine and Cellular Longevity
- Hesperidin: A Therapeutic Agent For Obesity
- (2019) Haijun Xiong et al. Drug Design Development and Therapy
- Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease
- (2019) Seyed Reza Mirhafez et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway
- (2019) Hossein Hosseini et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Naringin attenuates liver damage in streptozotocin-induced diabetic rats
- (2018) Valeria Rodríguez et al. BIOMEDICINE & PHARMACOTHERAPY
- Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial
- (2018) Sasan Amanat et al. CLINICAL NUTRITION
- Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- (2018) Vignan Manne et al. Clinics in Liver Disease
- Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products
- (2018) Gang Xu et al. CURRENT MEDICINAL CHEMISTRY
- Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial
- (2018) Konstantinos Kantartzis et al. DIABETES OBESITY & METABOLISM
- No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease
- (2018) Marianne K. Poulsen et al. DIABETES OBESITY & METABOLISM
- Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Somayyeh Asghari et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review
- (2018) Mohammad Bagherniya et al. PHARMACOLOGICAL RESEARCH
- Milk thistle (Silybum marianum ): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
- (2018) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Nonalcoholic Fatty Liver Disease
- (2018) Xiao Jing Wang et al. ANNALS OF INTERNAL MEDICINE
- Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes
- (2018) Eda Dokumacioglu et al. BIOMEDICINE & PHARMACOTHERAPY
- Structurally Different Flavonoid Subclasses Attenuate High-Fat and High-Fructose Diet Induced Metabolic Syndrome in Rats
- (2018) Jianan Zhang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic Fatty Liver Disease
- (2018) Irene Pierantonelli et al. TRANSPLANTATION
- Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
- (2018) Jana Hundertmark et al. Frontiers in Immunology
- Green Tea in Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial
- (2017) Seyed Mohammad Tabatabaee et al. Hepatitis Monthly
- Polyphenol-Rich Lentils and Their Health Promoting Effects
- (2017) Kumar Ganesan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Systematic Review and Meta-Analysis Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis
- (2017) Journal of Gastrointestinal and Liver Diseases
- The Essential Medicinal Chemistry of Curcumin
- (2017) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases
- (2017) Roya Navekar et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease
- (2017) Sheng Zhong et al. MEDICINE
- Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis
- (2017) Hossein Rafiei et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
- (2017) Alessandro Federico et al. MOLECULES
- Non-alcoholic fatty liver disease and flavonoids: Current perspectives
- (2017) Jung Hee Shin et al. Clinics and Research in Hepatology and Gastroenterology
- Dietary Anthocyanins against Obesity and Inflammation
- (2017) Yoon-Mi Lee et al. Nutrients
- PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway
- (2017) Yu Liu et al. Biomed Research International
- Nonalcoholic Fatty Liver Disease
- (2016) Rotonya M. Carr et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease
- (2016) Yunes Panahi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?
- (2016) Tarique Hussain et al. Oxidative Medicine and Cellular Longevity
- Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
- (2016) Sepideh Rahmani et al. PHYTOTHERAPY RESEARCH
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- (2015) Forouzan Faghihzadeh et al. BRITISH JOURNAL OF NUTRITION
- Health-promoting effects of the citrus flavanone hesperidin
- (2015) Chaoyun Li et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives
- (2015) Federico Salomone et al. LIVER INTERNATIONAL
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Bioavailability of anthocyanins
- (2014) Jim Fang DRUG METABOLISM REVIEWS
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Polyphenol Supplementation: Benefits for Exercise Performance or Oxidative Stress?
- (2014) Kathryn H. Myburgh SPORTS MEDICINE
- Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study
- (2013) RYUICHIRO SAKATA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Recent advances in understanding the anti-diabetic actions of dietary flavonoids
- (2013) Pon Velayutham Anandh Babu et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Novel insights of dietary polyphenols and obesity
- (2013) Shu Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties
- (2013) Sumit Bansal et al. NATURAL PRODUCT REPORTS
- Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
- (2013) Luca Valenti et al. Oxidative Medicine and Cellular Longevity
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Therapeutic potential of green tea in nonalcoholic fatty liver disease
- (2012) Christopher Masterjohn et al. NUTRITION REVIEWS
- Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms
- (2011) Guiyuan Ji et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Correction
- (2009) GUT
- Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
- (2008) Jing SHANG et al. ACTA PHARMACOLOGICA SINICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now